July 2, 2024 July 2, 2024Categories New TrialsNow Enrolling: This myeloMATCH trial is testing a new treatment for patients with acute myeloid leukemia that has a FLT3-ITD or D835 mutationThis study compares a standard initial treatment with a new approach that has the potential to put more patients into remission
January 5, 2023 January 5, 2023Categories Trial ResultsTrial Results: A recent ECOG-ACRIN study finds excellent results for patients with acute lymphoblastic leukemia (ALL)Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival
June 28, 2022 June 28, 2022Categories New TrialsNow Enrolling: The EA9213 clinical trial is testing a new treatment for patients with T-cell acute lymphoblastic leukemiaThis trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment
March 24, 2022 March 24, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Spring 2022Summaries of recently reported ECOG-ACRIN research results